The concentrated selling by OrbiMed (a sophisticated healthcare investor) and a director at an average price of ~$45.50 suggests insiders are monetizing near current levels. Monitor for any upcoming clinical data readouts, regulatory updates, or secondary offerings that could explain the urgency. The absence of any insider buying alongside this selling is a bearish signal.
Price Chart
Executive Summary
Two Sionna directors (OrbiMed Advisors and Peter Thompson) sold a combined $26.7M of stock over three days, representing ~1.3% of market cap. This is a material, concentrated sell-off by the company's largest institutional holder and a board member, occurring without any disclosed positive catalyst.
Key Financial Metrics
Key Facts
- Two directors sold a total of 586,904 shares for $26.7M over May 7-11, 2026.
- Total sales represent ~1.3% of SION's $2.0B market cap, exceeding the 0.5% materiality threshold.
- OrbiMed Advisors, a major institutional holder with board representation, sold 292,952 shares for $13.4M.
- Director Peter Thompson sold 292,952 shares for $13.4M in identical transactions.
- No insider purchases were reported in the cluster; the net direction is entirely selling.
- The cluster follows $31.7M in insider sales over the prior 30 days, accelerating the sell-off pattern.
Financial Impact
Total insider sales of $26.7M, representing 1.3% of SION's $2.0B market cap.
Risk Factors
- Insiders may be selling ahead of negative clinical trial results or regulatory setbacks.
- Continued insider selling could pressure the stock and signal lack of confidence in near-term catalysts.
- OrbiMed's large sell-down may indicate a strategic reduction in its position, potentially leading to further overhang.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SION-1778541268760 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 8-K | $4.50 $7.30 | ▼ −62.22% | ▼ −63.14% | $5.04 (−12.00%) |
Aug 6, 2026 8w ago | 8-K | $49.61 $6.75 | ▼ −86.39% | ▼ −86.99% | $5.04 (−89.84%) |
Jul 9, 2026 12w ago | Insider Cluster | $45.29 $51.04 | ▲ +12.70% | ▲ +10.27% | $5.04 (−88.87%) |
Jul 9, 2026 12w ago | Insider Cluster | $45.29 $51.04 | ▼ −12.70% | ▼ −10.27% | $5.04 (+88.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $44.00 $47.34 | ▼ −7.59% | ▼ −4.32% | $5.04 (+88.55%) |
Jul 2, 2026 13w ago | Insider Cluster | $43.99 $46.78 | ▲ +6.34% | ▲ +6.76% | $5.04 (−88.54%) |
Jun 11, 2026 16w ago | Institutional Cluster | $36.05 $44.94 | ▲ +24.66% | ▲ +22.77% | $5.04 (−86.02%) |
May 30, 2026 17w ago | Insider Cluster | $40.90 $43.99 | ▲ +7.55% | ▲ +8.85% | $5.04 (−87.68%) |
May 29, 2026 17w ago | 144 | $40.90 $43.99 | ▼ −7.55% | ▼ −8.85% | $5.04 (+87.68%) |
May 12, 2026 20w ago | 8-K | $40.94 $34.03 | ▼ −16.88% | ▼ −15.15% | $5.04 (−87.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access